Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Ardelyx
ARDX
$986M
| $2.14M | ﹤0.01% |
424,511
+165,357
| +64% | +$1.03M |
|
2252
State Street SPDR S&P Metals & Mining ETF
XME
$4.91B
| $2.14M | ﹤0.01% |
62,943
-8,867
| -12% | -$327K |
|
2253
PUT
UnitedHealth
UNH
$355B
| $2.14M | ﹤0.01% |
10,000
-20,000
| -67% | -$4.57M |
|
2254
PUT
iShares Biotechnology ETF
IBB
$10.8B
| $2.13M | ﹤0.01% |
+20,000
| New | +$2.22M |
|
2255
Univest Financial
UVSP
$1.15B
| $2.13M | ﹤0.01% |
+77,056
| New | +$2.16M |
|
2256
Comstock Resources
CRK
$4.29B
| $2.13M | ﹤0.01% |
+291,321
| New | +$2.35M |
|
2257
Universal Corp
UVV
$1.14B
| $2.13M | ﹤0.01% |
43,892
+32,940
| +301% | +$1.63M |
|
|
SYRS
2258
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.13M | ﹤0.01% |
+16,377
| New | +$1.79M |
|
|
CEO
2259
DELISTED
CNOOC Limited
CEO
| $2.12M | ﹤0.01% |
14,363
-67,013
| -82% | -$10.1M |
|
|
BCOV
2260
DELISTED
Brightcove, Inc.
BCOV
| $2.12M | ﹤0.01% |
305,383
-280,462
| -48% | -$1.95M |
|
|
NAGE
2261
Niagen Bioscience
NAGE
$254M
| $2.12M | ﹤0.01% |
504,525
-38,469
| -7% | -$201K |
|
|
STG
2262
Sunlands Technology
STG
$37.6M
| $2.12M | ﹤0.01% |
+20,405
| New | +$2.58M |
|
2263
Clean Energy Fuels
CLNE
$353M
| $2.12M | ﹤0.01% |
1,282,388
+277,147
| +28% | +$455K |
|
|
TBRG
2264
DELISTED
TruBridge
TBRG
| $2.11M | ﹤0.01% |
72,272
-233,069
| -76% | -$6.97M |
|
|
QTNA
2265
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $2.11M | ﹤0.01% |
+153,751
| New | +$2.14M |
|
2266
Vanguard Morningstar Value ETF
VTV
$193B
| $2.1M | ﹤0.01% |
20,374
-41,637
| -67% | -$4.47M |
|
2267
Williams-Sonoma
WSM
$28.1B
| $2.1M | ﹤0.01% |
+79,634
| New | +$2.11M |
|
|
HSTO
2268
DELISTED
Histogen Inc. Common Stock
HSTO
| $2.1M | ﹤0.01% |
1,788
-102
| -5% | -$113K |
|
2269
CGI
GIB
$15.4B
| $2.09M | ﹤0.01% |
36,261
-1,105
| -3% | -$62.7K |
|
2270
CALL
Prothena Corp
PRTA
$467M
| $2.08M | ﹤0.01% |
+69,900
| New | +$2.54M |
|
2271
Lennar Class B
LEN.B
$20.1B
| $2.08M | ﹤0.01% |
45,883
-3,642
| -7% | -$173K |
|
|
GBT
2272
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.08M | ﹤0.01% |
+43,000
| New | +$2.4M |
|
|
CYOU
2273
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $2.08M | ﹤0.01% |
74,382
-57,890
| -44% | -$1.78M |
|
2274
American Public Education
APEI
$844M
| $2.07M | ﹤0.01% |
48,180
+31,420
| +187% | +$964K |
|
|
CORE
2275
DELISTED
Core Mark Holding Co., Inc.
CORE
| $2.07M | ﹤0.01% |
97,461
+72,629
| +292% | +$1.64M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $2.48B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.